Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Other Non-Current Assets (2020 - 2025)

GoHealth's Other Non-Current Assets history spans 6 years, with the latest figure at $2.3 million for Q3 2025.

  • For Q3 2025, Other Non-Current Assets fell 22.03% year-over-year to $2.3 million; the TTM value through Sep 2025 reached $2.3 million, down 22.03%, while the annual FY2024 figure was $3.7 million, 64.76% up from the prior year.
  • Other Non-Current Assets for Q3 2025 was $2.3 million at GoHealth, down from $4.5 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $4.5 million in Q2 2025 and bottomed at $1.7 million in Q4 2022.
  • The 5-year median for Other Non-Current Assets is $2.5 million (2024), against an average of $2.7 million.
  • The largest annual shift saw Other Non-Current Assets skyrocketed 251.68% in 2021 before it plummeted 52.3% in 2022.
  • A 5-year view of Other Non-Current Assets shows it stood at $3.6 million in 2021, then tumbled by 52.3% to $1.7 million in 2022, then soared by 31.09% to $2.3 million in 2023, then surged by 64.76% to $3.7 million in 2024, then plummeted by 39.36% to $2.3 million in 2025.
  • Per Business Quant, the three most recent readings for GOCO's Other Non-Current Assets are $2.3 million (Q3 2025), $4.5 million (Q2 2025), and $3.3 million (Q1 2025).